The Globe and Mail reports in its Friday edition that more than 300 days past the legislated date, Ottawa has said it will begin its review of the Cannabis Act in order to assess the effects of legalization on health outcomes. The Globe's Irene Galia and David Milstead write that Health Minister Jean-Yves Duclos and Minister of Mental Health and Addictions Carolyn Bennett announced at a news conference Wednesday that the review will look at what the act has meant for public health, focusing on the consumption habits of young people and the impact on indigenous communities. The review is expected to take 18 months and will consider more than just health issues. It will also assess financial, tax, regulatory and criminal-justice matters. While the industry's financial viability will be considered by the five-member review panel, "the main focus is the safety and the health of Canadians," Mr. Duclos said. "This is a priority. Everything else is secondary to securing the health and safety of Canadians." Morris Rosenberg, a former president and chief executive officer of the Pierre Elliott Trudeau Foundation, will chair the panel. Health Canada is still recruiting the other four members of the panel.